Table 3.
Prevalence of symptom characteristics of COVID-19 in IgG+ individuals.
| Symptoms | First wave (%) | 95% IC | Second wave 2 (%) | 95% IC | p |
|---|---|---|---|---|---|
| Total | 275 (31.9) | – | 284 (50.1) | – | – |
| Fever | 134 (48.7) | 42–54 | 87 (30.6) | 25–36 | 0.0039 |
| Headache | 164 (60.0) | 53–65 | 176 (61.9) | 56–67 | 0.8334 |
| Coryza | 130 (47.6) | 41–53 | 143 (50.3) | 44–56 | 0.7240 |
| Cough | 145 (53.5) | 46–58 | 114 (40.1) | 34–45 | 0.0833 |
| Sore throat | 125 (46.2) | 39–51 | 148 (52.1) | 46–57 | 0.9842 |
| Body aches | 161 (58.9) | 52–64 | 132 (46.4) | 40–52 | 0.1276 |
| Abdominal pain | 73 (26.5) | 21–31 | 48 (16.9) | 12–21 | 0.0339 |
| Diarrhea | 86 (31.3) | 26–36 | 85 (29.9) | 24–36 | 0.8699 |
| Nausea | 59 (21.5) | 16–26 | 57 (20.0) | 15–24 | 0.8222 |
| Vomiting | 23 (8.0) | 0–4 | 24 (8.4) | 5–11 | 0.9062 |
| Loss of smell | 137 (50.5) | 43–55 | 85 (29.9) | 24–35 | 0.0021 |
| Loss of taste | 132 (48.4) | 42–53 | 89 (31.3) | 25–36 | 0.0100 |
| Shortness of breath | 65 (24.0) | 18–28 | 48 (16.9) | 12–21 | 0.1306 |
| Fatigue | 130 (48.0) | 41–53 | 118 (41.5) | 35–47 | 0.4419 |
Bold means the values are statiscally significant.